Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides
Clinical trial NCT04101331 · COMPLETED
Trial details
- NCT number
- NCT04101331
- Sponsor
- Affimed GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2022-05-11
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.